Previous Article | Next Article ![]()
Journal of Bacteriology, July 2007, p. 4662-4670, Vol. 189, No. 13
0021-9193/07/$08.00+0 doi:10.1128/JB.00180-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Kyle A. Kastead,2
Marina I. Savenkova,1
Charles M. Bulathsinghala,2 and
Kathleen Postle1,2*
School of Molecular Biosciences, Washington State University, Pullman, Washington 99164,1 Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania 168022
Received 3 February 2007/ Accepted 23 April 2007
|
|
|---|
7, lacking residues S157 to Y163) could still form disulfide-linked dimers when combined with W213C or F202C in the TonB carboxy terminus, the TonB
7 deletion did not prevent necessary energy-dependent conformational changes that occur in the CM. Thus, it appeared that initial contact with the OM is made through TonB residues S157 to Y163. It is hypothesized that the TonB Q160 region may be part of a large disordered region required to span the periplasm and contact an OM transporter. |
|
|---|
TonB, ExbB, and ExbD form a complex in the CM through their transmembrane domains (5, 22, 28, 31, 33, 34, 48, 60, 67, 73, 74). TonB is present in the CM as a dimer (19, 68). The TonB/ExbB/ExbD ratio in the cell is 1:7:2, although it is not known if this value reflects the ratio of the three proteins in an energy transduction complex (23, 26). Unlike ExbB and ExbD, approximately one-third of the total cellular TonB is found associated with the OM following sucrose density gradient fractionation (50). Present data suggest that TonB achieves OM association through a shuttling process whereby the entire protein transits out of the CM following initial OM contact and associates entirely with the OM (45, 50). Alternative mechanical models attribute TonB in the OM fractions to the superior strength of the association between the TonB carboxy terminus and OM transporters while in vivo TonB remains tethered to the OM. TonB can be dissociated from OM fractions by high salt concentrations (27). Although existing data support the shuttle model, the question of the TonB mechanism is not resolved, and the oligomeric state of TonB at the OM in vivo is not known. For recent reviews of the issues involved, see references (4, 11, and 63).
TonB transduces the protonmotive force into a different form of energy (chemical, mechanical, or stored conformational change) that enables active transport through OM transporters. The means by which TonB enables active transport through these unusual OM proteins is unknown (3, 66). The TonB-gated OM transporters are 22-stranded ß-barrels, with lumens that are occluded by an amino-terminal globular domain (also known as a cork; for reviews, see references 12, 13, 18, 37, 51, and 69). These transporters bind their ligands with subnanomolar affinities, and it is thus most likely the action of TonB that allows the release of the ligands into the periplasmic space. Periplasmic binding proteins retrieve the ligands and deliver them to ABC transporters in the CM (for a review, see reference 39).
At the extreme amino termini of the globular domains of TonB-gated OM transporters is a characteristic, periplasmically accessible sequence known as the TonB box, with which TonB amino acid residues in the region of Q160 can interact directly (8, 9, 57). The TonB box sequence is required for transporter activity (1, 24, 65, 66, 70). The defects in inactive TonB box missense mutants can be suppressed by mutations in TonB (Q160K, Q160L Q160P, or R158L) that do not appear to affect TonB activity (2, 6, 25). Group B colicins, protein toxins that kill sensitive strains of Escherichia coli, also use the TonB system to translocate across the OM. These colicins also have a TonB box at their amino termini (52).
One of several remaining questions is how the region around TonB Q160 participates in energy transduction. Even though mutations in the TonB box of OM transporter BtuB prevent vitamin B12 transport, the mutant BtuB TonB box continues to interact in vivo with residues in the TonB Q160 region; only the nature and efficiency of the interaction change (9). The nature of interactions between the TonB Q160 region and the TonB box also changes depending on the ligand that is being transported (10). In vitro in the absence of the TonB system, the BtuB TonB box becomes disordered and extends into the periplasmic space upon ligand addition (17, 53). In the cocrystal structure of BtuB with the TonB carboxy terminus, the TonB box of BtuB displaces the fourth ß-strand in TonB and joins the remaining three ß-strands as part of a ß-sheet (72). This arrangement brings TonB Q160 into proximity with the BtuB TonB box and provides a rationale for the inactive BtuB TonB box L8P and V10P mutant proteins. The TonB box mutant proteins would not be able to participate in the formation of a ß-sheet with TonB. It is less clear how the region around TonB Q160 would play a role, although a potentially important salt bridge between TonB R158 and BtuB D6 in the TonB box was identified. In the cocrystal structure of the ferrichrome OM transporter, FhuA, with the TonB carboxy terminus, the interaction of TonB R166 with FhuA Q56 in the globular domain was deemed to be important and hypothesized to mediate a mechanical shearing or pulling force resulting in the disruption of the globular domain to allow siderophore translocation. In the cocrystal structure, TonB R166 also interacts with FhuA A26 in the nonessential switch helix (15) of the globular domain (58) and two residues in the FhuA barrel, A591 and N594. Still less clear is how TonB suppressors of TonB box mutations may function.
While the importance of the TonB Q160 region seems obvious, it is not readily amenable to a scanning mutagenesis analysis. The replacement of TonB residues 159 to 164 individually with cysteine has no detectable effect on TonB activity (8). To begin to understand the function of this region of TonB, we engineered a series of mutant proteins with nested deletions centered on Q160. Here we show that, as we have observed in a previous study, deletions of residues at the TonB carboxy terminus have differential effects in assays for TonB activity (19, 20). The TonB Q160 region is not required for TonB activity since up to five residues centered on TonB Q160 can be deleted without inactivating TonB. TonB with a deletion of seven residues (S157 to Y163), however, did not associate with the OM and was inactive. Surprisingly, none of the arginyl residues in that region were required for TonB activity. The lowest level of activity observed in iron transport assays of mutants with single, double, or triple R
A substitutions was 70% of wild-type activity. Even the R154A R158A R166A R171A quadruple mutant TonB retained 30% of wild-type activity.
|
|
|---|
1,
3,
5, and
7 were also created in the plasmid backbones pKP472 (TonB C18G W213C) and pKP570 (TonB C18G F230C), and all amplified tonB genes were sequenced to rule out unintended base changes. The sequences of the primers are available upon request. |
View this table: [in a new window] |
TABLE 1. Strains and plasmids used in this study
|
A substitutions were generated from pKP325 by 30-cycle ultralong PCR using Pfu Ultra DNA polymerase from Stratagene. Forward and reverse primers were designed such that an alanine codon was substituted for the target arginine codon and flanked on either side by 12 to 16 homologous bases (primer sequences are available upon request). The template plasmid was removed by DpnI digestion, and mutations in the tonB gene were confirmed by cycle sequencing at The Pennsylvania State University Nucleic Acid Facility, University Park. Double, triple, and quadruple mutant plasmids were created by the same technique utilizing the single, double, and triple mutation-bearing plasmids, respectively, as templates. To avoid mutations occurring in unsequenced regions of the plasmid as a result of multiple PCR amplifications, all tonB genes corresponding to multiple amino acid substitutions were subcloned as a 914-bp BamHI fragment into plasmid pKP477 and proper orientation was confirmed by BstEII digestion. Medium and culture conditions. M9 salts were prepared as described by Miller (54). To prepare minimal media, M9 salts were supplemented with 0.2% Casamino Acids, 40 µg/ml tryptophan, 4 µg/ml thiamine, 1 mM MgSO4, 0.5 mM CaCl2, 1.85 µM Fe (as ferric chloride), and 0.4% glycerol as a carbon source. For the expression of TonB proteins from plasmids, 34 µg/ml chloramphenicol and 0.002% arabinose were added to the medium. Liquid cultures were supplemented with 34 µg/ml chloramphenicol.
Steady-state levels of TonB deletion mutant proteins.
The concentrations of arabinose required for the induction of TonB deletion mutant proteins to the level of chromosomally encoded TonB were determined to be 0.002% for TonB
7, TonB
9, and TonB
11 and 0.0005% for TonB
1, TonB
3, and TonB
5, as described previously (20). Cells were harvested at mid-exponential phase, precipitated with trichloroacetic acid, and analyzed by immunoblotting as described previously (42).
Sensitivity to colicins and bacteriophage.
The ability of plasmid-encoded TonB variants to support sensitivity to group B colicins and bacteriophage
80 was assayed with strain KP1406 (tonB aroB) as described previously (42). Cells were grown in M9 minimal medium supplemented with 1.85 µM Fe (as ferric chloride), 34 µg/ml chloramphenicol, and 0.002% arabinose and assayed on agar plates on top agar of the same composition. The results obtained were identical to those obtained with cells grown in tryptose broth (T-broth). The duplicate plate assays were repeated several times, and representative data are presented.
Sucrose density gradient fractionation. Strains were grown in M9 minimal medium supplemented with 1.85 µM Fe (as ferric chloride), 34 µg/ml chloramphenicol, and 0.002% arabinose and fractionated as described previously (19). Samples were resolved on 11% sodium dodecyl sulfate (SDS)-polyacrylamide gels (41) and evaluated by immunoblot analysis. The marker for the CM was NADH oxidase activity; the marker for the OM was the presence of a characteristic protein profile in OM fractions as determined by Coomassie blue staining of the polyvinylidene difluoride (PVDF) membrane following immunoblot analysis.
Cross-linking studies. In vivo formaldehyde cross-linking was carried out as described previously (28). Briefly, exponential-phase cultures in T-broth with 0.002% arabinose were harvested and suspended in 100 mM phosphate buffer, pH 6.8. Cells were then treated with 1% monomeric formaldehyde for 15 min and processed for immunoblot analysis. Samples were solubilized at 60°C for 5 min in Laemmli sample buffer to preserve cross-links.
For the detection of spontaneous in vivo disulfide-linked dimers, cells were grown to mid-exponential phase in T-broth supplemented with 0.2% arabinose. Cells were harvested and suspended in Laemmli sample buffer lacking ß-mercaptoethanol and supplemented with 50 mM iodoacetamide as described previously (19). Samples were resolved on 11% SDS-polyacrylamide gels (41) and evaluated by immunoblot analysis.
SDS-polyacrylamide gel electrophoresis and immunoblot analysis. Gel-resolved proteins were electrotransferred onto PVDF membranes. Immunoblot analysis was performed using TonB-specific monoclonal antibody 4F1, which recognizes a TonB epitope of residues 120 to 127 (46), and chemiluminescence detection as previously described (73). The loading of equivalent amounts of samples was confirmed by Coomassie staining of the PVDF membrane following immunoblot development.
Transport assays. Initial rates of [55Fe]ferrichrome transport were determined as described previously (40, 61).
|
|
|---|
1, the deletion of only Q160, to
3 (deletion of N159 to P161),
5 (deletion of R158 to Q162),
7 (deletion of S157 to Y163),
9 (deletion of L156 to P164), and
11 (deletion of A155 to A165). All of the plasmid-encoded mutant TonB proteins could be expressed to the level of chromosomally encoded TonB in KP1344 (tonB::blaM) (Fig. 1 and data not shown).
![]() View larger version (58K): [in a new window] |
FIG. 1. Steady-state levels of TonB deletion variants. Upper panel: TonB expressed from the wild-type chromosome of W31100 (chr) and from strains KP1344/pKP325 (wild type [wt]), KP1344/pKP477 (TonB; tonB), KP1344/pKP489 (TonB 1), KP1344/pKP490 (TonB 3), KP1344/pKP491 (TonB 5), KP1344/pKP513 (TonB 7), and KP1344/pKP493 (TonB 9). Samples used for the upper panel were the source of iron transport data for the wild-type, TonB 5, TonB 7, and TonB 9 strains in Table 2. Lower panel: TonB expressed from the wild-type chromosome of W31100 (chr) and from strains KP1344/pKP325 (wt), KP1344/pKP477 (TonB; tonB), KP1344/pKP489 (TonB 1), KP1344/pKP490 (TonB 3), and KP1344/pKP491 (TonB 5). Samples used for the lower panel were the source of iron transport data for the TonB 1 and TonB 3 strains in Table 2. Samples were resolved on an 11% acrylamide gel and immunoblotted, and TonB was detected with anti-TonB antibodies.
|
1) had various effects on colicin sensitivity phenotypes. While retaining approximately 70% of wild-type ferrichrome transport rates and sensitivity to colicin Ia and bacteriophage
80, cells expressing TonB
1 became completely insensitive to colicin D and were nearly insensitive to colicins B and M, with incomplete zones of clearing at every dilution after the fourth (Table 2). These results were reminiscent of those obtained with alanyl substitutions at aromatic residues in the TonB carboxy terminus, when differential phenotypes were observed depending on the assay used (20). In addition, changes in this region have previously been associated with phenotypic decreases specific to colicin B or colicin D sensitivity (7, 55). This result indicated that Q160 was not essential for TonB activity, consistent with previous results (78). |
View this table: [in a new window] |
TABLE 2. Phenotypic characterization of mutants with TonB Q160 region deletions
|
3) greatly decreased TonB activity in every assay and resulted in complete sensitivity to colicins B, D, and M, a 106-fold decrease in
80 sensitivity, incomplete zones of colicin Ia clearing at all dilutions where sensitivity was observed, and an inability to support ferrichrome transport (Table 2). The deletion of residues 158 to 162 (TonB
5) unexpectedly restored sensitivity to the sixth fivefold dilution of colicin B, undiluted colicin D, and the fifth fivefold dilution of colicin M and full sensitivity to colicin Ia and bacteriophage
80, while the initial rate of ferrichrome transport increased to 60% of the wild-type rate. Plasmid-expressed TonB proteins with deletions of seven or more amino acids (TonB
7, TonB
9, and TonB
11) were inactive in all assays.
The Q160 region is involved in OM association in sucrose density gradients.
The deletion mutations affected a region of TonB known to interact with the OM transporters through the TonB box. The inactivity of deletion mutant proteins TonB
3 and TonB
7, TonB
9, and TonB
11 suggested that, unlike wild-type TonB, they would not be able to associate with the OM. To test this idea, cells expressing mutant proteins were fractionated on sucrose density gradients, with the result that only the relatively active mutant proteins TonB
1 and TonB
5 were able to associate significantly with the OM (Fig. 2). The TonB
11 mutant protein had the same fractionation profile as the TonB
7 and TonB
9 mutant proteins (data not shown).
![]() View larger version (49K): [in a new window] |
FIG. 2. Inactive TonB variants with deletions in the Q160 region do not associate with the OM. Immunoblots of sucrose density gradient fractionations are shown, each labeled with respect to the bacterial strain fractionated. WT, wild type (KP1344/pKP325); 1, KP1344/pKP489; 3, KP1344/pKP490; 5, KP1344/pKP491; 7, KP1344/pKP513; and 9, KP1344/pKP493. Samples were resolved on an 11% acrylamide gel and immunoblotted, and TonB was detected with anti-TonB antibodies. The positions of CM and OM fractions are indicated. The position of monomer TonB on each immunoblot is indicated by an arrowhead. Fractions containing soluble TonB degradation products are indicated by an asterisk. NADH oxidase activities (NADHox), in units (1 unit = 1 µmol/min NADH oxidized), and specific gravities of each fraction are indicated below each immunoblot.
|
1 and TonB
5 exhibited the OM degradation pattern characteristic of wild-type TonB, with significant levels of degradation products that were slightly smaller than full-length TonB and significant accumulation of degradation products at the dye front (50). Consistent with that idea, the TonB
3 mutant showed little evidence of functional interaction with the OM in that it entirely lacked the OM degradation products. The small amount of full-length TonB
3 at the OM may reflect the small amount of CM contamination that occurs in this procedure. The inactive mutant proteins TonB
7, TonB
9, and TonB
11 were unstable, as evidenced by the high proportion of degradation products relative to the full-length protein in the CM. Most importantly, due to the absence of any degradation products in the OM beyond levels that would arise from contamination with the CM, there is no evidence that they could ever associate with the OM. The TonB
1, TonB
5, TonB
7, TonB
9, and TonB
11 mutants had the unusual feature of degradation products that appeared in the soluble fractions of the gradient, as well as the CM (indicated by the asterisks in the relevant lanes of Fig. 2). The proportion of apparently soluble degradation products appeared to increase as greater portions of TonB were deleted.
Inactive TonB deletion mutant proteins do not cross-link to FepA.
To determine whether the deleted regions were required for TonB interaction with various proteins, strains expressing the TonB deletions were cross-linked in vivo with formaldehyde, and their cross-linking profiles were compared to that of the wild type (Fig. 3). It has recently been shown that the cross-links of TonB to OM proteins Lpp and FepA represent unenergized TonB (19). Here, the results tended to mirror the transport results rather than those of the colicin and phage sensitivity assays, with TonB
1 and TonB
5 forming cross-linked complexes with FepA (73). TonB
1 formed complexes with Lpp and ExbB; however, it was not clear whether TonB
5 also formed these complexes since the candidate bands appeared at slightly different molecular masses (27, 28). The nature of the interactions of TonB
3, TonB
7, TonB
9, and TonB
11 with the OM proteins Lpp and FepA was changed such that no characteristic cross-links were detectable (Fig. 3 and data not shown). TonB
3 and TonB
7 apparently retained the ability to cross-link to ExbB. Unidentified complexes appeared in several of the mutants.
![]() View larger version (79K): [in a new window] |
FIG. 3. Inactive TonB 3 and TonB 7 deletion variants do not cross-link to FepA or Lpp. Strains expressing wild-type (wt) TonB (KP1344/pKP325), TonB 1 ( 1; KP1344/pKP489), TonB 3 ( 3; KP1344/pKP490), TonB 5 ( 5; KP1344/pKP491), and TonB 7 ( 7; KP1344/pKP513) were cross-linked with formaldehyde as described in Materials and Methods. Samples were resolved on an 11% acrylamide gel and immunoblotted, and TonB was detected with anti-TonB antibodies. Positions of characteristic cross-linked complexes of TonB with Lpp, ExbB, and FepA are indicated by arrowheads on the left. The positions of monomeric TonB and a degradation (Deg) product are also indicated.
|
1 through
7 on disulfide dimer formation by the TonB carboxy terminus, the deletions were engineered in plasmid-carried tonB W213C C18G and tonB F230C C18G genes and the expressed proteins were analyzed by immunoblotting on nonreducing SDS-polyacrylamide gels (Fig. 4). The protein variants with Q160-centered deletions retained the ability to form disulfide-linked dimers, indicating that none of the TonB Q160 region deletions interfered with the ability to achieve a conformation associated with an energetically competent TonB protein.
![]() View larger version (82K): [in a new window] |
FIG. 4. Both active and inactive TonB variants with deletions in the Q160 region can form disulfide-linked dimers through the TonB carboxy-terminal Cys substitutions at aromatic residue W213 or F230. Strains expressing wild-type TonB ( 0; KP1344/pKP325), TonB 1 ( 1; KP1344/pKP489), TonB 3 ( 3; KP1344/pKP490), TonB 5 ( 5; KP1344/pKP491), and TonB 7 ( 7; KP1344/pKP513) were harvested at mid-exponential phase and processed by boiling in gel sample buffer that lacked a reducing agent and contained 50 mM iodoacetamide. Samples were resolved on an 11% acrylamide gel and immunoblotted, and TonB was detected with anti-TonB antibodies. Identities of the TonB variants in each sample are indicated above each lane. The positions of the three characteristic disulfide-linked dimers are indicated by arrowheads. The position of monomeric TonB is indicated. Degradation products are indicated by an asterisk.
|
5 mutant compared to the TonB
3 mutant suggested that the deletion of five residues restored an important sequence or relationship that was lacking when three residues were deleted. A comparison of the sequences remaining after deletion suggested that a pair of arginyl residues spaced six to seven residues apart might be important for TonB activity (Fig. 5). In addition, arginyl residues at TonB 158 and 166 were recently identified as making important contacts with BtuB and FhuA, respectively, in cocrystals with the TonB carboxy-terminal domain (58, 72).
![]() View larger version (13K): [in a new window] |
FIG. 5. Amino acid sequences of TonB variants with deletions in the Q160 region. Arg residues are underlined. Residue numbers are indicated at the end of each line. The types of deletions and the relative activities of the variants are indicated on the left.
|
20%. In contrast, colicin and phage sensitivity assays can overestimate the levels of TonB activity (42). Both single R
A substitutions and all combinations of double R
A substitutions had little effect on iron transport rates. The four triple substitutions retained 70 to 75% of wild-type TonB activity. Surprisingly, the quadruple R154A R158A R166A R171A TonB mutant protein still supported an iron transport rate of 30% of the wild-type rate. |
View this table: [in a new window] |
TABLE 3. Arginyl residues in the TonB Q160 region are not essential for TonB activity
|
|
|
|---|
To explore TonB-transporter interactions from the TonB perspective, we began a nested deletion analysis of the region centered on TonB Q160 to create TonB
1, TonB
3, TonB
5, TonB
7, TonB
9, and TonB
11. Sensitivity to bacteriophage
80 requires as little as 1 molecule of TonB per cell for detection (42). In the bacteriophage sensitivity assay, TonB
5 (lacking residues 158 to 162) was fully as sensitive as wild-type TonB, while TonB
7, TonB
9, and TonB
11 were entirely insensitive to
80 and inactive in all the other assays. Sensitivity to group B colicins combines two variables: first, the ability of TonB to interact with the OM transporter that serves as the colicin receptor, and second, most likely the ability to interact with the colicin itself, since group B colicins also have an essential TonB box at their amino termini (52). TonB
5 was severely impaired in colicin D sensitivity but retained full sensitivity to colicin Ia and slightly reduced sensitivity to colicins B and M. The test of the ability to transport iron is an assay that can discriminate between levels of TonB in the 20 to 100% range and thus provides the most accurate, time-sensitive estimate of TonB impairment (42). In this assay, TonB
5 was still able to support ferrichrome transport at 60% of the wild-type rate. Taken together, these results led to the surprising possibility that, in spite of its apparent importance in suppressing TonB box mutations, the five-residue region centered on TonB Q160 (TonB
5) was not essential to wild-type TonB activity. To put this in perspective, a single H20A substitution in the amino-terminal transmembrane domain of TonB eliminates all the TonB activities assayed as described above (43). Thus, the TonB suppressor alleles most likely represent novel gain-of-function mutations, although it is not clear what that function may be.
The ability of residues in the region surrounding TonB Q160 to discriminate between colicin D and colicin B has been observed previously (55). The two colicins are 96% identical throughout the first 313 amino acids that constitute the amino-terminal translocation domain (including the TonB box) and a central receptor-binding domain. They diverge in their carboxy-terminal killing domains, where colicin B has a pore-forming toxicity domain (64) and the colicin D toxicity domain is a tRNase (75). One difference between the translocation domains of these two colicins occurs in the TonB box, where colicin B has aspartyl and threonyl residues and colicin D has histidyl and seryl residues. Whereas wild-type TonB confers sensitivity to both colicins, in the work of Mora et al., TonB R158S and TonB P161L mutants were shown to be specifically insensitive to colicin D while retaining sensitivity to colicin B (55). Because these two colicins use the same OM receptor, FepA, the difference in the patterns of sensitivity of the TonB R158S and P161L mutants must be due entirely to interactions with the colicins themselves. The interactions of TonB R158S and TonB P161L with colicins are not, however, confined to the colicin TonB box regions. The TonB R158S and TonB P161L mutants exhibited only slightly decreased sensitivity to colicin B after the conversion of the colicin B TonB box into a colicin D TonB box (D17, T18
H17, S18). By analogy, it seems likely, therefore, that the interaction of TonB with OM transporters may not be confined solely to the transporter TonB box.
To further understand the TonB Q160 region, we attempted to discover why, when TonB
3 was almost entirely inactive, activity could be largely restored by the deletion of two additional residues. Our hypothesis was that the maintenance of correct spacing between arginyl residues previously suggested to be important in cocrystal structures of the TonB carboxy terminus with BtuB or FhuA was the key. The number of residues between R158 and R166 is seven. TonB
1 and TonB
5 both had a space of six to seven residues between arginyl residues (Fig. 5) and were both highly active. TonB
3, TonB
7, TonB
9, and TonB
11 had fewer numbers of residues between the arginyl residues, which correlated with their lack of activity. This hypothesis was refuted: TonB with alanyl substitutions at any three of four arginyl residues retained between
70 and 75% of wild-type TonB activity. Even TonB with substitutions at all four arginyl residues retained
30% of wild-type activity. Although charged residues can be important in protein-protein interactions, we conclude that TonB R154, R158, R166, and R171 are not essential for TonB-mediated energy transduction.
The phenotypic activities of the TonB variants with deletions centered on Q160 correlated best with their abilities to associate with the OM in sucrose density gradients, where only TonB
1 and TonB
5 associated with the OM and gave rise to the same proteolysis pattern in the OM as wild-type TonB. TonB
3 associated only slightly with the OM and had very little detectable activity. In addition, it lacked the proteolytic products that characterize active TonB. TonB
7, TonB
9, and TonB
11 in the CM fractions degraded significantly. There were also no full-length or proteolytic degradation products to suggest that they ever associated with the OM. Additionally, even though the in vivo formaldehyde cross-links between TonB and FepA represent interactions made by unenergized TonB (19), they at least represent a capacity for some sort of interaction between the two proteins. TonB
3 and TonB
7 (as well as TonB
9 and TonB
11) (data not shown) lacked even this capacity. We have previously shown that TonB Q160 is not in itself sufficient for OM association (44).
The deletion mutations yielded variants that were successively more sensitive to proteases in the cytoplasmic fractions, with TonB
7, TonB
9, and TonB
11 being so sensitive that very little full-length TonB was detectable. Although we have never previously detected soluble forms of TonB, here, soluble degradation products appeared in all the mutants except the TonB
3 mutant. These soluble fragments may arise from either the amino or carboxy termini of the deletion mutant proteins. If they arose from the carboxy terminus, they may represent a stable form of TonB similar to that observed in the crystal and nuclear magnetic resonance (NMR) structures. In the monomeric NMR structure, the TonB residues from 103 to 151 are unstructured (59). If the fragments contained the extreme amino terminus, they could have arisen by dissociation after shuttling to the OM (45). We have been unsuccessful in our efforts to determine the origin of these important soluble pieces of TonB.
The inability of TonB mutant proteins with Q160 region deletions to interact with OM proteins was not due to an inability of the carboxy terminus to form an energized conformation at the CM. At the initiation of energy transduction in the CM, the TonB carboxy terminus apparently has to fold correctly through an intermediate where the five aromatic residues F180, F202, W213, Y215, and F230 come into sufficiently close contact that disulfide-linked dimers form when cysteine is substituted for F202, W213, Y215, or F230 (19, 20). The dimers must be resolved into an unknown conformation for TonB to proceed to associate with the OM. When coupled with TonB W213C or F230C, the tested deletion mutant proteins (TonB
1, TonB
3, TonB
5, and the inactive TonB
7) were not impaired in the formation of disulfide-linked dimers, indicating that the region centered on TonB Q160 is not essential for that energy-dependent conformational change.
Taken together, the data suggest that residues centered on TonB Q160 constitute the region through which TonB forms an initial, stable association with OM transporters. This idea raises the question of how the Q160 region transits across the
200-Å periplasmic space to contact OM transporters. While the proline-rich domain of TonB (residues 70 to 102) that precedes Q160 may serve as a 100-Å arm to facilitate that contact (16), it is not essential for TonB activity (49, 71). In the cocrystal structure with OM transporters FhuA and BtuB, the TonB carboxy terminus (residues 153 to 235) occupies only
25 Å (58, 72). Presumably, a different structure is required to initiate contact with OM transporters.
One hypothesis is that the (broadly defined) TonB carboxy terminus is held in an unstructured or disordered conformation by ExbB/ExbD to allow the induced-fit recognition of ligand-bound OM transporters (43, 63). This hypothesis is consistent with much of our knowledge about protein disorder (14) and about TonB protein. First, disordered proteins are often modular, with independent domains. The TonB amino terminus can undergo a protonmotive force-dependent conformational change in vivo in the absence of the carboxy terminus (47), the carboxy terminus can bind independently to OM transporters (30, 35, 36, 38), and the intervening proline-rich region between the two domains can be deleted without affecting TonB activity. Second, the independent disordered domains act like beads on a string where the linker serves to allow a search by the attached domain. TonB searches for a ligand-bound OM transporter and does not transduce energy unless the search is successful (47). Third, protein ligands for binding can also be disordered prior to binding. In vivo, the BtuB TonB box appears to be disordered (10). Fourth, coupled folding and binding of the disordered domain often result in high specificity and low affinity, which are important for dissociation and reassociation at a new site. TonB must interact with numerous different ligands and dissociate after each interaction in order to be recharged for a subsequent round of energy transduction (32).
Consistent with these ideas, large regions of TonB are predicted to be disordered (43), and in the NMR structure of the monomeric TonB carboxy terminus (residues 101 to 239), residues from 101 to 151 are indeed disordered (59). It seems reasonable to speculate that ExbD, which has the same topology as TonB, may serve as the chaperone to manage the various conformational changes (possibly disorder-order transitions) that TonB goes through during an energy transduction cycle (47).
This work was supported by NIH grant GM42146 to K.P.
Published ahead of print on 4 May 2007. ![]()
Present address: Mandel & Adriano Intellectual Property, 55 S. Lake Ave., Suite 710, Pasadena, CA 91101. ![]()
|
|
|---|
V17) by a missense mutation in ExbB. Mol. Microbiol. 13:627-640.[CrossRef][Medline]This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»